Stelios Papadopoulos

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Alameda, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Nina Ayer, Attorney in Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Stelios Papadopoulos

Form 4 holding Director

BIOGEN INC.

Security class
Common Stock
Shares / value
17,375
Estimated value
$4,309,000
Report date
15 Jun 2022
Price
$248.00
Ownership
Stelios Holdings, LLC
Form 4 holding Director

BIOGEN INC.

Security class
Common Stock
Shares / value
10,831
Estimated value
$2,686,088
Report date
15 Jun 2022
Price
$248.00
Ownership
Esperanza Holdings, LLC
Form 4 holding Director

BIOGEN INC.

Security class
Common Stock
Shares / value
10,095
Estimated value
$2,503,560
Report date
15 Jun 2022
Price
$248.00
Ownership
Direct
Form 4 holding Director

Ovid Therapeutics Inc.

Security class
Stock Option (right to buy)
Shares / value
90,000
Estimated value
Report date
03 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Ovid Therapeutics Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
65,000
Estimated value
Report date
26 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

EXELIXIS, INC.

Security class
Option (right to buy)
Shares / value
0
Estimated value
Report date
15 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Stelios Papadopoulos

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .